Switzerland-based Actelion ( ALIOF ) recently submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the approval of its pulmonary arterial hypertension
We downgrade our recommendation on Buckeye Partners L.P. ( BPL ) to Underperform from Neutral in view of highly volatile fuel and diesel prices which could negatively influence the